CIO

JANUARY 3, 2024

There’s bias in both the training data sets and in the results, and there are ethical concerns, runaway costs, integration challenges, model drift, lack of transparency, data security risks, plagiarism risks, and regulatory risks. In addition, for particularly sensitive business information and data, he expects to see even more security.

Alliance 755

Alliance Due Diligence Pharmaceutical Technology 755

Alpha Sense BI

MAY 28, 2024

Startups that survive the funding drought and succeed in securing allocations will be those with experienced, executive-level leadership and compelling customer-centric solutions. These prospects are more likely to secure financing ahead of their more risky, underdeveloped counterparts.

Capital 69

Capital Startups Biotech Due Diligence 69

Alpha Sense BI

DECEMBER 12, 2023

These intangible factors indicate that even the most exhaustive due diligence processes can still leave gaps in the M&A research process. Comprehensive Due Diligence Thorough due diligence on a target company is undeniably the cornerstone of successful M&A.

Due Diligence 52

Due Diligence Primary Research Competitive Intelligence Market Intelligence 52

Alpha Sense BI

FEBRUARY 6, 2024

Clinical Pipelines and Drug Developments – Assessing the pipeline of pharmaceutical and biotechnology companies by analyzing clinical trials to gauge the potential success of new drugs or therapies in development.

Research 98

Research Primary Research Due Diligence Competitive Positioning 98

Alpha Sense BI

DECEMBER 15, 2023

Massive Data Analysis It’s clear that the pharmaceutical industry is increasingly in need of handling and interpreting expansive datasets efficiently and accurately. In the realm of supplier relations, AI applications provide transparency and foster collaboration between pharmaceutical companies and their partners.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52

Alpha Sense BI

FEBRUARY 3, 2023

ESG investing –it’s a market trend that’s gained traction with ethical investors, multi-billion dollar companies, mammoth private equity firms, and recently, the Securities and Exchange Commission (SEC) and International Sustainability Standards Board ( ISSB ). timber, natural pharmaceuticals) and services (i.e.,

Finance 98

Finance Due Diligence Banking Pharmaceutical 98

Alpha Sense BI

APRIL 12, 2024

Although, they’re trying to make TPU as a more open framework.” – Former Head of Engineering, Google | Expert Transcript When a pharmaceutical company launches a new drug, how do you know if the benefits to patients outweigh the side effects and costs? If you’re going to force me into TPU, that’s like locking me in.

Primary Research 52

Primary Research Advantage Advantage Research 52